336 related articles for article (PubMed ID: 25885043)
1. The leukemia inhibitory factor (LIF) and p21 mediate the TGFβ tumor suppressive effects in human cutaneous melanoma.
Humbert L; Ghozlan M; Canaff L; Tian J; Lebrun JJ
BMC Cancer; 2015 Mar; 15():200. PubMed ID: 25885043
[TBL] [Abstract][Full Text] [Related]
2. TGF-beta inhibits human cutaneous melanoma cell migration and invasion through regulation of the plasminogen activator system.
Humbert L; Lebrun JJ
Cell Signal; 2013 Feb; 25(2):490-500. PubMed ID: 23085456
[TBL] [Abstract][Full Text] [Related]
3. RASSF8 regulates progression of cutaneous melanoma through nuclear factor-κb.
Wang J; Hua W; Huang SK; Fan K; Takeshima L; Mao Y; Hoon DS
Oncotarget; 2015 Oct; 6(30):30165-77. PubMed ID: 26334503
[TBL] [Abstract][Full Text] [Related]
4. Cyclin D1 cooperates with p21 to regulate TGFβ-mediated breast cancer cell migration and tumor local invasion.
Dai M; Al-Odaini AA; Fils-Aimé N; Villatoro MA; Guo J; Arakelian A; Rabbani SA; Ali S; Lebrun JJ
Breast Cancer Res; 2013 Jun; 15(3):R49. PubMed ID: 23786849
[TBL] [Abstract][Full Text] [Related]
5. Impact of LIF (leukemia inhibitory factor) expression in malignant melanoma.
Kuphal S; Wallner S; Bosserhoff AK
Exp Mol Pathol; 2013 Oct; 95(2):156-65. PubMed ID: 23831429
[TBL] [Abstract][Full Text] [Related]
6. A novel function for p21Cip1 and acetyltransferase p/CAF as critical transcriptional regulators of TGFβ-mediated breast cancer cell migration and invasion.
Dai M; Al-Odaini AA; Arakelian A; Rabbani SA; Ali S; Lebrun JJ
Breast Cancer Res; 2012 Sep; 14(5):R127. PubMed ID: 22995475
[TBL] [Abstract][Full Text] [Related]
7. Leukemia inhibitory factor inhibits the proliferation of gastric cancer by inducing G1-phase arrest.
Xu G; Wang H; Li W; Xue Z; Luo Q
J Cell Physiol; 2019 Apr; 234(4):3613-3620. PubMed ID: 30565675
[TBL] [Abstract][Full Text] [Related]
8. Nucleosome assembly protein 1-like 4, a new therapeutic target for proliferation and invasion of melanoma cells.
Mizuhashi S; Fukushima S; Ishibashi T; Kuriyama H; Kimura T; Kanemaru H; Kajihara I; Makino K; Miyashita A; Aoi J; Kita K; Ihn H
J Dermatol Sci; 2021 Apr; 102(1):16-24. PubMed ID: 33583643
[TBL] [Abstract][Full Text] [Related]
9. miR-4262 promotes the proliferation of human cutaneous malignant melanoma cells through KLF6-mediated EGFR inactivation and p21 upregulation.
Zhang D; Li Z; Zhang Y; Tu C; Huo J; Liu Y
Oncol Rep; 2016 Dec; 36(6):3657-3663. PubMed ID: 27779691
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of long noncoding RNA FALEC predicts poor prognosis and promotes melanoma cell proliferation through epigenetically silencing p21.
Ni N; Song H; Wang X; Xu X; Jiang Y; Sun J
Biomed Pharmacother; 2017 Dec; 96():1371-1379. PubMed ID: 29196104
[TBL] [Abstract][Full Text] [Related]
11. High LIFr expression stimulates melanoma cell migration and is associated with unfavorable prognosis in melanoma.
Guo H; Cheng Y; Martinka M; McElwee K
Oncotarget; 2015 Sep; 6(28):25484-98. PubMed ID: 26329521
[TBL] [Abstract][Full Text] [Related]
12. Sodium ascorbate inhibits growth via the induction of cell cycle arrest and apoptosis in human malignant melanoma A375.S2 cells.
Lin SY; Lai WW; Chou CC; Kuo HM; Li TM; Chung JG; Yang JH
Melanoma Res; 2006 Dec; 16(6):509-19. PubMed ID: 17119452
[TBL] [Abstract][Full Text] [Related]
13. Cell cycle arrest and apoptosis of melanoma cells by docosahexaenoic acid: association with decreased pRb phosphorylation.
Albino AP; Juan G; Traganos F; Reinhart L; Connolly J; Rose DP; Darzynkiewicz Z
Cancer Res; 2000 Aug; 60(15):4139-45. PubMed ID: 10945621
[TBL] [Abstract][Full Text] [Related]
14. P21 and Bax expression in cutaneous malignant melanomas: correlation with histologic prognostic parameters.
Poyraz A; Akyürek N; Gönül II; Erdem O
J Exp Clin Cancer Res; 2004 Dec; 23(4):625-31. PubMed ID: 15743033
[TBL] [Abstract][Full Text] [Related]
15. Tumor growth suppressive effect of IL-4 through p21-mediated activation of STAT6 in IL-4Rα overexpressed melanoma models.
Lee HL; Park MH; Song JK; Jung YY; Kim Y; Kim KB; Hwang DY; Yoon do Y; Song MJ; Han SB; Hong JT
Oncotarget; 2016 Apr; 7(17):23425-38. PubMed ID: 26993600
[TBL] [Abstract][Full Text] [Related]
16. Leukemia inhibitory factor promotes EMT through STAT3-dependent miR-21 induction.
Yue X; Zhao Y; Zhang C; Li J; Liu Z; Liu J; Hu W
Oncotarget; 2016 Jan; 7(4):3777-90. PubMed ID: 26716902
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-365 Inhibits Cell Growth and Promotes Apoptosis in Melanoma by Targeting BCL2 and Cyclin D1 (CCND1).
Zhu Y; Wen X; Zhao P
Med Sci Monit; 2018 Jun; 24():3679-3692. PubMed ID: 29858490
[TBL] [Abstract][Full Text] [Related]
18. KiSS1 gene as a novel mediator of TGFβ-mediated cell invasion in triple negative breast cancer.
Tian J; Al-Odaini AA; Wang Y; Korah J; Dai M; Xiao L; Ali S; Lebrun JJ
Cell Signal; 2018 Jan; 42():1-10. PubMed ID: 28988968
[TBL] [Abstract][Full Text] [Related]
19. Leukemia inhibitory factor promotes tumor growth and metastasis in human osteosarcoma via activating STAT3.
Liu B; Lu Y; Li J; Liu Y; Liu J; Wang W
APMIS; 2015 Oct; 123(10):837-46. PubMed ID: 26271643
[TBL] [Abstract][Full Text] [Related]
20. Leukemia inhibitory factor promotes gastric cancer cell proliferation, migration, and invasion via the LIFR-Hippo-YAP pathway.
Bian SB; Yang Y; Liang WQ; Zhang KC; Chen L; Zhang ZT
Ann N Y Acad Sci; 2021 Jan; 1484(1):74-89. PubMed ID: 32827446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
